Bovilis Covexin 8

Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Tetani-Perfringens Types C & D Bacterin-Toxoid

For Animal Use Only

Bovilis Covexin 8 Indications

This product has been shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. tetani, and C. perfringens Type C & D. This product was licensed prior to the requirement to establish a minimum age for use. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.

ADMINISTRATION AND DOSAGE: Mix gently. Use aseptic technique.

CATTLE DOSAGE: Inject 5 mL subcutaneously or intramuscularly, repeated in 6 weeks. For advice on revaccination frequency, contact your veterinarian.

SHEEP DOSAGE: Inject 5 mL subcutaneously followed by a 2 mL dose in 6 weeks. For advice on revaccination frequency, contact your veterinarian. Vaccination should be scheduled so that pregnant ewes receive their second vaccination or annual booster 2 to 6 weeks before lambing commences in the flock. Historically, vaccination of lambs for their primary course beginning at 10-12 weeks of age was recommended. Consult a veterinarian or the manufacturer for advice on vaccination.

PRESERVATIVE: Thimerosal.

Bovilis Covexin 8 Caution

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant animals. Local reactions may be observed following subcutaneous administration to cattle. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY.

Manufactured by

Schering-Plough Animal Health Limited, Upper Hutt, New Zealand

Distributed by

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 311/PCN 7380.00

1 800 521-5767 (USA)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047033.4